Investing.com – Amgen (NASDAQ:AMGN) reported on Thursday third quarter earnings that beat analysts’ forecasts and revenue that topped expectations.
Amgen announced earnings per share of $4.70 on revenue of $6.7B. Analysts polled by Investing.com anticipated EPS of $4.45 on revenue of $6.58B.
Amgen shares are up 18% from the beginning of the year, still down 3.27% from its 52 week high of $274.88 set on November 2.
Amgen shares gained 1.02% in after-hours trade following the report.
Amgen’s report follows an earnings beat by UnitedHealth on October 14, who reported EPS of $5.79 on revenue of $80.9B, compared to forecasts EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on October 18 with third quarter EPS of $2.55 on revenue of $23.79B, compared to forecast for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar
We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.